PFE Mar 2025 42.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:30AM EDT. Market open.
| Previous close | 0.2000 |
| Open | 0.1600 |
| Bid | 0.1300 |
| Ask | 0.2200 |
| Strike | 42.50 |
| Expiry date | 2025-03-21 |
| Day's range | 0.1600 - 0.1900 |
| Contract range | N/A |
| Volume | |
| Open interest | 7.8k |
Yahoo FinanceAmgen's peek at its GLP-1 drug trial results heightens competition in obesity market
Competition is heating up in the GLP-1 space as Amgen gets closer to the finish line with its candidate.
GuruFocus.comVanguard Health Care Fund's Strategic Moves in Q1 2024: A Focus on Pfizer Inc
Insight into the Fund's Latest Investment Decisions and Stock Adjustments
ZacksPharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
Eli Lilly (LLY), Novo Nordisk (NVO), Pfizer (PFE) and AbbVie (ABBV) announce their first-quarter results.
© 2024 Yahoo. All rights reserved.